Prostate Cancer BCR Risk Not Linked to Statin Use
Over a median follow-up of 70 months, 15% of men studied experienced biochemical recurrence.
Over a median follow-up of 70 months, 15% of men studied experienced biochemical recurrence.
Data from 21 observational studies showed an 8% increased risk of prostate cancer.
Use of 5ARIs for BPH was associated with a statistically significant increased, pooled relative risk for sexual dysfunction.
PPI use was associated with 10% increased odds of CKD and 76% increased odds of death.
Patients who underwent a radical cystectomy (RC) developed postoperative infection after a median of 13 days.
CIN developed in 14.7% of patients with low hemoglobin levels compared with 5% of those with normal levels.
Medical research inherently seeks to improve approaches to clinical care.
Patients with diabetes had a significant 42% increased risk of recurrence of cancer and 79% increased risk of progression.
Researchers’ results showed that the presence of a urinary catheter and recent antibiotic use were associated with increased odds of intra-operative bacteremia.
The recurrence group had significantly larger tumors than the no-recurrence group.